$VICP

VICAPSYS LIFE SCIENCES

Pharmaceutical preparations · Pink Limited

0.400 +0.00% as of 10/29/2026, 2:31:54 AM · delayed

Sentiment

BULLISH BEARISH

No open positions yet.

No threads yet for $VICP. Be the first to post.

Official links

Filings

15-12G Thu Mar 27 2025 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
3 Fri Mar 21 2025 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
SCHEDULE 13G Fri Mar 21 2025 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
10-Q Fri Jan 10 2025 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov View
10-Q Fri Jan 10 2025 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov View
10-Q Fri Jan 10 2025 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov View
10-K Mon Oct 21 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
SEC STAFF ACTION Thu Jun 27 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov

All filings

Timeline

import 9/20/2026 VICP added from Pink Limited universe
filing 3/26/2025 15-12G filed
filing 3/20/2025 3 filed
filing 3/20/2025 SCHEDULE 13G filed
filing 1/9/2025 10-Q filed
filing 1/9/2025 10-Q filed
filing 1/9/2025 10-Q filed
filing 10/20/2024 10-K filed
filing 6/26/2024 SEC STAFF ACTION filed
filing 12/26/2023 8-K filed

Company reliability

–

No resolved statements yet.

Revenue

No SEC revenue data.

CEO compensation

$250K (FY 2023)

Federico Pier (current CEO) - $370K total disclosed since 2022

Federico Pier

10-K

Provisional - extracted from filings, not verified.

FY 2022 $120K extracted
FY 2021 $90K extracted

Notes & debt

Provisional - extracted from filings, not verified.

IN DEFAULT · $2.4M in arrears (+1 with unknown amounts)
$40K matured Dec 31, 2023 10-Q · 2025-01-10

Quote

NOTE 6 – SHORT-TERM LIABILITIES Convertible Note Payable As discussed in Note 2, on June 27, 2023, the Board of Directors approved a resolution authorizing the Company to obtain a secured six-month term loan for the principal amount of $ 330,000 .
$363K matured Jan 27, 2024 10-Q · 2025-01-10

Quote

F- 14 Debt Modification On December 26, 2023, the Company and the note holder entered into a letter agreement under which an agreement was made to extend the maturity date of the Note to January 27, 2024 , increase the principal of the note to $ 363,000 , and amend the convertible note to extend the date on which the Company shall prepare and file with the SEC a registration statement covering the resale of all of the conversion shares and commitment fee to January 27, 2024.
$33K matured Feb 27, 2024 10-Q · 2025-01-10

Quote

On February 6, 2024, the Company and convertible note holder entered into a letter agreement under which an agreement was made to extend the maturity date of the note to February 27, 2024 , increase the principal of the convertible note to $ 399,300 , extend the date on which the Company shall prepare and file the resale registration statement with the SEC to February 27, 2024, and extend the registration effective date for the resale registration statement until April 27, 2024.
$330K matured Sep 30, 2024 10-Q · 2025-01-10

Quote

NOTE 6 – SHORT-TERM LIABILITIES Convertible Note Payable 1 As discussed in Note 2, on June 27, 2023, the Board of Directors approved a resolution authorizing the Company to obtain a secured six-month term loan for the principal amount of $ 330,000 .
$21K matured Oct 31, 2024 10-Q · 2025-01-10

Quote

NOTE 8 – SUBSEQUENT EVENTS In relation to the convertible note payable discussed in Note 6, in April 2024, the note holders agreed to extend the maturity date of the convertible note to October 31, 2024, and any accrued but unpaid interest through the date thereof shall be due and payable on or before October 31, 2024.
$95K matured Oct 31, 2024 10-Q · 2025-01-10

Quote

In July 2024, entered into a promissory note agreement for the principal amount of $ 95,000 .
$50K matured Oct 31, 2024 10-Q · 2025-01-10

Quote

In April 2024, the note holders agreed to extend the maturity date of the convertible note to October 31, 2024 , and any accrued but unpaid interest through the date thereof shall be due and payable on or before October 31, 2024.
— matured Oct 31, 2024 10-Q · 2025-01-10

Quote

The Company subsequently failed to repay the convertible note on or before January 27, 2024, and failed to file the resale registration statement on or before January 27, 2024.
$55K matured May 10, 2025 10% 10-Q · 2025-01-10

Quote

The maturity date on the promissory note is May 10, 2025 and carries an annual interest rate of 10 %.
$95K — 10-Q · 2025-01-10

Quote

In connection with the convertible promissory note, to secure the note, the Company paid a commitment fee by issuing 300,000 shares of the Company’s common stock.
$95K — 10-Q · 2025-01-10

Quote

In December 2024, the note holder agreed to and issued a one-time waiver applicable to the default and failure to comply with the purchase agreement debt modifications through December 31, 2024 In July 2024, entered into a convertible promissory note agreement for the principal amount of $95,000.
$290K — 10-Q · 2025-01-10

Quote

As of the date of this filing, the Company is in default of the terms of the six-month term loan purchase agreement as the Company failed to repay the convertible note on or before October 31, 2024, and also failed to file the resale registration statement on or before October 31, 2024 per the terms of the debt modification agreement.
$330K — 10-Q · 2025-01-10

Quote

In connection therewith, the Company entered into a Securities Purchase Agreement with selected accredited investors whereby the Company secured a convertible promissory note in the amount of $330,000, which was issued with an original issuance discount of $26,400 and resulted in aggregate proceeds of $303,600.
$21K — 10-Q · 2025-01-10

Quote

NOTE 8 – SUBSEQUENT EVENTS As of the date of this filing the Company is in default with the terms of the convertible notes discussed in Note 6.
$3K — 10-Q · 2025-01-10

Quote

Interest expense incurred related to the short-term note payable for the year ended December 31, 2023 was approximately $ 3,459 .
$95K — 10-Q · 2025-01-10

Quote

In connection therewith, on July 17, 2024, the Company entered into a Securities Purchase Agreement with selected accredited investors whereby the Company had the right to secure the convertible note.
$33K — 10-Q · 2025-01-10

Quote

The Company subsequently failed to repay the convertible note on or before January 27, 2024, and failed to file the resale registration statement on or before January 27, 2024.
$330K — 10-Q · 2025-01-10

Quote

In connection therewith, on June 27, 2023, the Company entered into a Securities Purchase Agreement with selected accredited investors whereby the Company had the right to secure the convertible note.
$95K — 10-Q · 2025-01-10

Quote

In July 2024, entered into a promissory note agreement for the principal amount of $95,000.
NEARING / AGED
$0 — 10-Q · 2025-01-10

Quote

In connection with the promissory note as discussed in Note 7, to secure the note, the Company paid a commitment fee by issuing 328,571 shares of the Company’s common stock.
$84K — 10-Q · 2025-01-10

Quote

The convertible note is also presented net of the debt discount of $ 83,526 which represents the relative fair value of the common stock issued as of December 31, 2023, which will accrete over the life of the convertible note.
$0 — 10-Q · 2025-01-10

Quote

In connection with the convertible promissory note as discussed in Note 6, to secure the note, the Company paid a commitment fee by issuing 300,000 shares of the Company’s common stock.
$84K — 10-Q · 2025-01-10

Quote

The convertible note is also presented net of the debt discount of $ 83,526 which represents the relative fair value of the common stock issued as of June 30, 2023, which will accrete over the life of the convertible note.
$84K — 10-Q · 2025-01-10

Quote

The convertible note is also presented net of the debt discount of $ 83,526 which represents the relative fair value of the common stock issued, which was fully recognized as of September 30, 2024.
OTHER ISSUANCES
$449K — 13.9% 10-Q · 2025-01-10

Quote

Short-Term Note Payable The Company entered into a commercial insurance premium finance and security agreement in May 2023.
$19K — 13.9% 10-Q · 2025-01-10

Quote

The Company had an outstanding premium balance of approximately $ 12,546 and $ 18,712 at March 31, 2024 and December 31, 2023, respectively, related to the agreement, which is included in short-term note payable in the consolidated balance sheets.
$6K — 13.9% 10-Q · 2025-01-10

Quote

Short-Term Note Payable The Company entered into a commercial insurance premium finance and security agreement in May 2023.
$37K — 13.9% 10-Q · 2025-01-10

Quote

The Company had an outstanding premium balance of approximately $ 12,546 and $ 36,789 at September 30, 2024 and 2023, respectively, related to the agreement, which is included in short-term note payable in the consolidated balance sheets.
$17K — 13.9% 10-Q · 2025-01-10

Quote

Short-Term Note Payable The Company entered into a commercial insurance premium finance and security agreement in May 2023.
$55K — 10-Q · 2025-01-10

Quote

In connection with the convertible promissory note, to secure the note, the Company paid a commitment fee by issuing 300,000 shares of the Company’s common stock.
$449K — 10-Q · 2025-01-10

Quote

The balance of the convertible note as of March 31, 2024, was $ 449,300 .
$330K — 10-Q · 2025-01-10

Quote

NOTE 6 – SHORT-TERM LIABILITIES Convertible Note Payable As discussed in Note 2, on June 27, 2023, the Board of Directors approved a resolution authorizing the Company to obtain a secured six-month term loan for the principal amount of $ 330,000 .
$84K — 10-Q · 2025-01-10

Quote

The Company did not incur any accretion expense related to the original issuance discount for the three months ended March 31, 2024, and 2023. 15 Debt Discount To secure the convertible note, the Company paid a commitment fee of $ 83,526 by issuing 328,571 shares of the Company’s common stock.
$36K — 10-Q · 2025-01-10

Quote

The convertible note is also presented net of the debt discount of $ 35,625 which represents the relative fair value of the common stock issued which will accrete over the life of the loan based on the effective interest method.
$75K — 10-Q · 2025-01-10

Quote

Debt Discount 2 To secure the convertible note, the Company paid a commitment fee of $ 75,000 by issuing 300,000 shares of the Company’s common stock.
$6K — 10-Q · 2025-01-10

Quote

The convertible note is also presented net of the issuance costs of $ 5,750 which will accrete over the life of the note, based on the effective interest method.
$13K — 10-Q · 2025-01-10

Quote

The convertible note is also presented net of the issuance costs of $ 13,250 which will accrete over the life of the note, based on the effective interest method.
No notes match this filter.

Top predictors

No resolved predictions on $VICP yet.

Upcoming resolutions

Nothing awaiting resolution.